Solution-phase parallel synthesis of a pharmacophore library of HUN-7293 analogues: A general chemical mutagenesis approach to defining structure-function properties of naturally occurring cyclic (depsi)peptides

被引:52
作者
Chen, Y
Bilban, M
Foster, CA
Boger, DL
机构
[1] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[3] Novartis Forschungsinstitut, A-1235 Vienna, Austria
关键词
D O I
10.1021/ja020166v
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
HUN-7293 (1), a naturally occurring cyclic heptadepsipeptide, is a potent inhibitor of cell adhesion molecule expression (VCAM-1,ICAM-1, E-selectin), the overexpression of which is characteristic of chronic inflammatory diseases. Representative of a general approach to defining structure-function relationships of such cyclic (depsi)peptides, the parallel synthesis and evaluation of a complete library of key HUN-7293 analogues are detailed enlisting solution-phase techniques and simple acid-base liquid-liquid extractions for isolation and purification of intermediates and final products. Significant to the design of the studies and unique to solution-phase techniques, the library was assembled superimposing a divergent synthetic strategy onto a convergent total synthesis. An alanine scan and N-methyl deletion of each residue of the cyclic heptadepsipeptide identified key sites responsible for or contributing to the biological properties. The simultaneous preparation of a complete set of individual residue analogues further simplifying the structure allowed an assessment of each structural feature of 1, providing a detailed account of the structure-function relationships in a single study. Within this pharmacophore library prepared by systematic chemical mutagenesis of the natural product structure, simplified analogues possessing comparable potency and, in some instances, improved selectivity were identified. One potent member of this library proved to be an additional natural product in its own right, which we have come to refer to as HUN-7293B (8), being isolated from the microbial strain F/94-499709.
引用
收藏
页码:5431 / 5440
页数:10
相关论文
共 61 条
[31]   VCAM-1/alpha 4-integrin adhesion pathway: Therapeutic target for allergic inflammatory disorders [J].
Foster, CA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (06) :S270-S277
[32]  
FOSTER CA, 1994, JOURNAL OF DERMATOLOGY, VOL 21, NO 11, NOVEMBER 1994, P847, DOI 10.1111/j.1346-8138.1994.tb03300.x
[33]   SELECTIVE REMOVAL OF AN N-BOC PROTECTING GROUP IN THE PRESENCE OF A TERT-BUTYL ESTER AND OTHER ACID-SENSITIVE GROUPS [J].
GIBSON, FS ;
BERGMEIER, SC ;
RAPOPORT, H .
JOURNAL OF ORGANIC CHEMISTRY, 1994, 59 (11) :3216-3218
[34]  
Glover JM, 1997, J PHARMACOL EXP THER, V282, P1173
[35]   Solution- and solid-phase strategies for the design, synthesis, and screening of libraries based on natural product templates: A comprehensive survey [J].
Hall, DG ;
Manku, S ;
Wang, F .
JOURNAL OF COMBINATORIAL CHEMISTRY, 2001, 3 (02) :125-150
[36]   The 3D-structure of a natural inhibitor of cell adhesion molecule expression [J].
Hommel, U ;
Weber, HP ;
Oberer, L ;
Naegeli, HU ;
Oberhauser, B ;
Foster, CA .
FEBS LETTERS, 1996, 379 (01) :69-73
[37]   Chemical synthesis of natural product peptides: Coupling methods for the incorporation of noncoded amino acids into peptides [J].
Humphrey, JM ;
Chamberlin, AR .
CHEMICAL REVIEWS, 1997, 97 (06) :2243-2266
[38]   Combinatorial biosynthesis for new drug discovery [J].
Hutchinson, CR .
CURRENT OPINION IN MICROBIOLOGY, 1998, 1 (03) :319-329
[39]   Repeat treatment of rheumatoid arthritis patients with a murine anti-intercellular adhesion molecule 1 monoclonal antibody [J].
Kavanaugh, AF ;
SchulzeKoops, H ;
Davis, LS ;
Lipsky, PE .
ARTHRITIS AND RHEUMATISM, 1997, 40 (05) :849-853
[40]   ELECTROPHILIC AROMATIC-SUBSTITUTION WITH N-METHOXY-N-ACYLNITRENIUM IONS GENERATED FROM N-CHLORO-N-METHOXYAMIDES - SYNTHESES OF NITROGEN HETEROCYCLIC-COMPOUNDS BEARING A N-METHOXYAMIDE GROUP [J].
KAWASE, M ;
KITAMURA, T ;
KIKUGAWA, Y .
JOURNAL OF ORGANIC CHEMISTRY, 1989, 54 (14) :3394-3403